Navigation Links
A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology

and the techniques of fixation, embedding and staining in late 19th century,40 with continued technical development including lenses of higher numerical aperture, magnification and contrast methods, light microscopes have been important tools for the biological studies of cells and tissues, and identifying micro-organisms causing diseases.16-18 In fact, the cell theory was started based on microscopic observations. Application of CLSM started to increase rapidly in the 1990s, due to the increased availability of confocal systems thanks to advances in optics, electronics and computer technology, and newly developed fluorochromes with better matching laser lines and brighter fluorescence.41 Applications of CLSM include fluorescence detection of gene expression profiling using cDNA microarrays,42 fluorescence volume investigation and reconstruction of tissue samples,43 identification of diagnostic markers,44 and so on.

In molecular drug discovery, DNA and tissue microarrays are playing more and more important roles. The availability of multi-tumor analysis helps overcome the issues of time consumption, intensive labor, and cost in validation of multiple pathogenic markers on multiple cancer tissue specimens.38 Although the technique of TMAs provides the potential of high-throughput data acquisition, only through highly efficient imaging systems with microscopic resolution can the potential be realized.

1.3. wide field-of-view Confocal Microscopy

The wide field-of-view confocal imaging system presented in this paper is capable of confocal imaging of large area specimen in a single scan, e.g., imaging an entire standard microscope slide (1 by 3 inches in size) without tiling, while a conventional widefield light microscope or confocal microscope using microscope obj
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals
2. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
3. High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system
4. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
5. Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system
6. Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system
7. Multiplex protein detection with the ECL Plex fluorescent Western blotting system using the Ettan DIGE Imager
8. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
9. Amplified Fragment Length Polymorphism (AFLP) Analysis on Applied Biosystems Capillary Electrophoresis Systems
10. A technique for increasing yields in bioreactors and disposable cell-culture systems
11. An Assessment of the Eppendorf twin.tec plate performance in PCR* applications
Post Your Comments:
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Medicine, recently presented new data on the relationship of genetics and hypertension at ... Congress on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts ...
(Date:8/26/2015)... VANCOUVER , Aug. 26, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... continue pre-clinical activities with respect to our Oral ... of a contract manufacturer," said Andrew Rae ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, ... the development and manufacture of highly valued cardiac markers used in early detection ... expertise with protein chemistry has led to the development and commercialization of important ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... CAMBRIDGE, Mass., Jan. 12 Cequent Pharmaceuticals, a pioneer ... treatments to prevent and treat human disease, announced that ... officer. Mr. Hibben comes to Cequent from Coley Pharmaceutical ... business development and alliance management and played a key ...
... Human Genome Sciences, Inc. (Nasdaq: HGSI ... Annual JPMorgan Healthcare Conference will be webcast and may ... )A member of Human Genome Sciences, senior management ... Wednesday, January 14, 2009 at 7:30 am Pacific Time ...
... to Enable Stockholders to Determine Fate of Company,s ... Avigen Stockholders Extraordinary Risk/Reward OpportunitySAN FRANCISCO, Jan. 9 ... affiliates ("BVF") today announced that it has requested ... ("Avigen") (Nasdaq: AVGN ) call a ...
Cached Biology Technology:Cequent Names Ted Hibben Chief Business Officer 2Cequent Names Ted Hibben Chief Business Officer 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 2Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 4Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 5
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors ... growth in applications, penetration into newer sectors, and development ... The global biosensors space has seen the entry of ... market so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ... Sullivan, Analysis of the Global Biosensors Market ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... 2015 La 10 th International Conference on ... BGI del 22 al 25 de octubre de 2015 en ... la conferencia celebra su décimo aniversario. Desde su inauguración en ... las reuniones anuales más influyentes del mundo en el campo ... entusiastas y mejores a nivel científico. ICG-10 ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... CA., April 7 . . .A new study ... a proprietary blend extracted from canola, Dermytol, produces a ... proprietary compound developed by KGK Synergize Inc., a biotechnology ... cells from damage that may lead to skin cancer. ...
... most people fear as they grow older, but autopsy data ... the Seattle region found that the brains of a third ... of small vessel damage: the type of small, cumulative injury ... Montine, University of Washington, presented the study results at Experimental ...
... beginning to develop a clearer picture of what makes some ... of researchers who last year identified the first common version ... twenty regions of the genome which together can make a ... published together with two independent studies online today in the ...
Cached Biology News:New study shows Dermytol produces pronounced decrease in malignant melanoma tumor volume 21/3 of risk for dementia attributable to small vessel disease, autopsy study shows 2A tall story: New research adds to growing body of knowledge of genetics of height 2
...
...
... rapidly and reliably amplify unknown genomic DNA ... provides hassle-free, ready-to use components, at an ... provided in each kit. The Genome Walking ... localized cloning of genomic DNA, isolating promoter ...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: